PPARG and urinary bladder cancer: It has been proposed that PPARγ agonists are not free from side effects including edema, headache, hypoglycemia, myalgia, HF, weight gain, bone fractures, increased risk of MI and mortality, and possibly bladder cancer [13, 14, 17, 102–104].